Numerous non-randomized studies have compared the outcomes of radiotherapy and surgery for clinically localized prostate cancer.
These outcomes include the risk of biochemical recurrence and cancer-specific survival. Some studies have found no significant difference in oncologic outcomes, whereas others give the edge to one or other. But factors other than oncologic outcomes influence the treatment decision, such as whether a patient is a good surgical candidate and patients’ personal preference (such as an aversion to surgery).
Renal & Urology News would like to know what urologists’ experience has been, so please answer the following poll question:
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.